Authors

• Takuya Takahashi (ORCID: https://orcid.org/0000-0001-6523-0622)
• Kengo Yonezawa
• Sadamitsu Ichijo (ORCID: https://orcid.org/0000-0001-8135-5740)
• Hiroyuki Uchida (ORCID: https://orcid.org/0000-0002-0628-7036)
• Yu Fujimoto (ORCID: https://orcid.org/0000-0001-8475-0535)
• Sakiko Tsugawa (ORCID: https://orcid.org/0000-0001-9974-316X)
• Tomoyuki Miyazaki (ORCID: https://orcid.org/0000-0003-3840-5436)
• Nobuhiro Nagai (ORCID: https://orcid.org/0000-0003-2826-4959)
• Keisuke Kusudo
• Takashige Yamada (ORCID: https://orcid.org/0000-0002-1152-9853)
• Shinichiro Nakajima (ORCID: https://orcid.org/0000-0002-2601-2195)
• Taisuke Yatomi
• Hideaki Tani (ORCID: https://orcid.org/0000-0002-8782-0399)
• Sotaro Moriyama
• Yohei Ohtani (ORCID: https://orcid.org/0009-0007-1313-0049)
• Shiori Honda (ORCID: https://orcid.org/0000-0002-3756-0584)
• Hiroshi Morisaki (ORCID: https://orcid.org/0000-0002-2790-2093)
• Yu Iwabuchi (ORCID: https://orcid.org/0000-0002-9259-6651)
• Tsuyoshi Eiro
• Kie Nomoto‐Takahashi
• Kimio Yoshimura
• Sota Tomiyama
• Masahiro Jinzaki

Institutions

• Keio University (JP)
• Zero to Three (US)
• Sapporo Minami Hospital (JP)
• Yokohama City University (JP)

Publication Details

Journal

Psychiatry and Clinical Neurosciences

Published

2024-08-30

DOI

https://doi.org/10.1111/pcn.13734

Citations

9

Primary Topic

Treatment of Major Depression

Type

article

Field-Weighted Citation Impact

4.03

Funders

• Takeda Science Foundation
• Japan Research Foundation for Clinical Pharmacology
• Japan Agency for Medical Research and Development
• Boehringer Ingelheim Japan
• Keio University
• Dainippon Sumitomo Pharma
• Eisai
• Meiji Seika Pharma
• Shionogi
• Otsuka Pharmaceutical
• SENSHIN Medical Research Foundation
• Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering
• H. Lundbeck A/S
• Japan Society for the Promotion of Science
• Japan Science and Technology Agency
• Daiichi Sankyo Europe